Aptar Pharma wins CE marking for LuerVax intranasal vaccine device

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. SAP
7. CSX
8. LRCX
9. KNX
10. ELV

Go back to Aptar Pharma wins CE marking for LuerVax intranasal vaccine device

Aptar Announces CE Marking for LuerVax® and Accompanying Spray Divider, Strengthening Support for Vaccine Developers

October 14, 2026 5:00 PM EDT

Milestone strengthens Aptar Pharmas support for intranasal vaccine development from clinical studies through commercialization

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)-- Aptar Pharma, part of AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that its LuerVax® intranasal delivery device and accompanying Spray Divider have been CE marked under the EU Medical Device Regulation (MDR), indicating that they meet the European general safety and performance requirements for medical devices. This milestone expands Aptar Pharmas support for customers developing innovative... More